NASDAQ:PRQR

Proqr Therapeutics N.v Stock Forecast

etoro logo Buy PRQR
*Your capital is at risk
$1.73
-0.0300 (-1.70%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of PRQR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRQR to Watchlist?
  • Easy Tracking In The Watchlist
PDF

ProQR Therapeutics N.V. stock price down 1.70% on Friday
(Updated on Jul 10, 2026)

Hold candidate since Jul 08, 2026 Gain 2.98%

The ProQR Therapeutics N.V. stock price fell by -1.70% on the last day (Friday, 10th Jul 2026) from $1.76 to $1.73. During the last trading day the stock fluctuated 6.63% from a day low at $1.66 to a day high of $1.77. The price has been going up and down for this period, and there has been a 10.19% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 549 thousand shares were bought and sold for approximately $950.43 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.19% during the next 3 months and, with a 90% probability hold a price between $1.37 and $1.84 at the end of this 3-month period.

PRQR Signals & Forecast

The ProQR Therapeutics N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.73 and $1.61. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -8.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

ProQR Therapeutics N.V. finds support from accumulated volume at $1.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.110 between high and low, or 6.63%. For the last week the stock has had daily average volatility of 9.04%.

Our recommended stop-loss: $1.63 (-5.49%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (PRQR) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect ProQR Therapeutics N.V. to open at $1.72, and during the day (based on 14 day Average True Range), to move between $1.65 and $1.81, which gives a possible trading interval of +/-$0.157 (+/-9.51%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 9.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.75 (1.16%) than the support at $1.68 (2.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProQR Therapeutics N.V. stock A Buy?

ProQR Therapeutics N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.026 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $1.72 ( 0.578%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRQR Performance

Trading levels for PRQR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.83 5.78%
R2 1.79 3.35%
R1 1.76 1.85%
Price 1.73
S1 1.68 -3.01%
S2 1.65 -4.51%
S3 1.61 -6.94%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.89 9.25%
R2 1.83 5.78%
R1 1.75 1.16%
Price 1.73
S1 1.68 -2.89%
S2 1.57 -9.25%
S3 1.53 -11.56%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the Jul 10, 2026, the price of an ProQR Therapeutics N.V. (PRQR) share was $1.73.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.10 and the 52-week low is $1.34.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the Jul 10, 2026, the market capitalization of ProQR Therapeutics N.V. is 182.185M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PROQR THERAPEUTICS N.V.
ProQR Therapeutics N.V
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE